Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva M Weissinger

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Frontiers in Oncology|September 5, 2022
Navigating preemptive and therapeutic donor lymphocyte infusions in advanced myeloid malignancies by high-sensitivity chimerism analysisMichael Stadler, Letizia Venturini, Ivonne Bünting, et al.
Plos One|December 29, 2012
Sequential anti-cytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantationSylvia Borchers, Melanie Bremm, Thomas Lehrnbecher, et al.
Hepatology (Baltimore, Md.)|March 5, 2011
Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasisTim O Lankisch, Jochen Metzger, Ahmed A Negm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2011
Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromesFelicitas Thol, Inna Friesen, Frederik Damm, et al.
Frontiers in Pharmacology|May 9, 2015
Long term follow up of patients after allogeneic stem cell transplantation and transfusion of HSV-TK transduced T-cellsEva M Weissinger, Sylvia Borchers, Anna Silvani, et al.
Annals of Hematology|April 11, 2012
Prognostic significance of combined MN1, ERG, BAALC, and EVI1 (MEBE) expression in patients with myelodysplastic syndromesFelicitas Thol, Haiyang Yun, Ann-Kathrin Sonntag, et al.
Cytotherapy|August 29, 2020
Cell culture media notably influence properties of human mesenchymal stroma/stem-like cells from different tissuesAndreas Winkel, Yarúa Jaimes, Catharina Melzer, et al.
Bone Marrow Transplantation|February 22, 2023
Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working PartyRaffaella Greco, Jorinde D Hoogenboom, Edouard F Bonneville, et al.
Proteomics. Clinical Applications|February 5, 2010
CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnosticsJoshua J Coon, Petra Zürbig, Mohammed Dakna, et al.
Proteomics. Clinical Applications|December 8, 2010
Clinical proteomics: A need to define the field and to begin to set adequate standardsHarald Mischak, Rolf Apweiler, Rosamonde E Banks, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Frontiers in Oncology|September 5, 2022
Navigating preemptive and therapeutic donor lymphocyte infusions in advanced myeloid malignancies by high-sensitivity chimerism analysisMichael Stadler, Letizia Venturini, Ivonne Bünting, et al.
Plos One|December 29, 2012
Sequential anti-cytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantationSylvia Borchers, Melanie Bremm, Thomas Lehrnbecher, et al.
Hepatology (Baltimore, Md.)|March 5, 2011
Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasisTim O Lankisch, Jochen Metzger, Ahmed A Negm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2011
Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromesFelicitas Thol, Inna Friesen, Frederik Damm, et al.
Frontiers in Pharmacology|May 9, 2015
Long term follow up of patients after allogeneic stem cell transplantation and transfusion of HSV-TK transduced T-cellsEva M Weissinger, Sylvia Borchers, Anna Silvani, et al.
Annals of Hematology|April 11, 2012
Prognostic significance of combined MN1, ERG, BAALC, and EVI1 (MEBE) expression in patients with myelodysplastic syndromesFelicitas Thol, Haiyang Yun, Ann-Kathrin Sonntag, et al.
Cytotherapy|August 29, 2020
Cell culture media notably influence properties of human mesenchymal stroma/stem-like cells from different tissuesAndreas Winkel, Yarúa Jaimes, Catharina Melzer, et al.
Bone Marrow Transplantation|February 22, 2023
Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working PartyRaffaella Greco, Jorinde D Hoogenboom, Edouard F Bonneville, et al.
Proteomics. Clinical Applications|February 5, 2010
CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnosticsJoshua J Coon, Petra Zürbig, Mohammed Dakna, et al.
Proteomics. Clinical Applications|December 8, 2010
Clinical proteomics: A need to define the field and to begin to set adequate standardsHarald Mischak, Rolf Apweiler, Rosamonde E Banks, et al.
Pageof 6